Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The effects of Lyprinol® on delayed onset muscle soreness and muscle damage in well trained athletes: a double-blind randomised controlled trial

Date

Authors

Pumpa, Kate L

Fallon, Kieran

Bensoussan, Alan

Papalia, Shona

Publisher

Churchill Livingstone

Abstract

Objectives: The aim of the study was to determine if Lyprinol ® is effective in reducing pain, indicators of inflammation and muscle damage, and in turn improving performance in well trained athletes suffering from delayed onset muscle soreness (DOMS). D

Keywords

Keywords: C reactive protein; creatine kinase; interleukin 1; interleukin 10; interleukin 6; lyprinol; myoglobin; tumor necrosis factor alpha; absence of side effects; adult; algometer; article; athlete; blood analysis; controlled clinical trial; controlled study; Acute phase response; DOMS; Exercise; Lyprinol ®; Muscle damage; Recovery

URI

http://hdl.handle.net/1885/25295

Collections

ANU Research Publications

Source

Complementary Therapies in Medicine

Type

Journal article

DOI

10.1016/j.ctim.2011.08.004

Restricted until

2037-12-31

Downloads

File

Description

01_Pumpa_The_effects_of_Lyprinol®_on_2011.pdf (47.72 KB)

02_Pumpa_The_effects_of_Lyprinol®_on_2011.pdf (185.54 KB)

abcd